# Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain

> **NCT02455609** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 90 (estimated)

## Conditions studied

- Therapy
- Pain Management

## Interventions

- **PROCEDURE:** intrathecal drug administration
- **DRUG:** Dexmedetomidine
- **DRUG:** ketamine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT02455609
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455609, "Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02455609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
